News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,081 Results
Type
Article (13900)
Company Profile (68)
Press Release (249113)
Multimedia
Podcasts (5)
Webinars (2)
Section
Business (70949)
Career Advice (361)
Deals (14267)
Drug Delivery (16)
Drug Development (34619)
Employer Resources (30)
FDA (7016)
Job Trends (5961)
News (128913)
Policy (12467)
Tag
Academia (1197)
Academic (1)
Accelerated approval (3)
Adcomms (9)
Allergies (36)
Alliances (19490)
ALS (45)
Alzheimer's disease (576)
Antibody-drug conjugate (ADC) (61)
Approvals (7087)
Artificial intelligence (114)
Autoimmune disease (13)
Automation (11)
Bankruptcy (102)
Best Places to Work (5020)
BIOSECURE Act (2)
Biosimilars (38)
Biotechnology (48)
Bladder cancer (57)
Brain cancer (10)
Breast cancer (166)
Cancer (1396)
Cardiovascular disease (101)
Career advice (319)
Career pathing (7)
CAR-T (60)
Cell therapy (180)
Cervical cancer (15)
Clinical research (28970)
Collaboration (478)
Compensation (525)
Complete response letters (5)
COVID-19 (1073)
CRISPR (18)
C-suite (116)
Cystic fibrosis (45)
Data (1340)
Depression (13)
Diabetes (134)
Diagnostics (4038)
Digital health (9)
Diversity, equity & inclusion (9)
Drug discovery (54)
Drug pricing (9)
Drug shortages (3)
Duchenne muscular dystrophy (37)
Earnings (26163)
Editorial (7)
Employer branding (6)
Employer resources (28)
Events (37595)
Executive appointments (414)
FDA (7697)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (414)
Gene editing (42)
Generative AI (5)
Gene therapy (142)
GLP-1 (309)
Government (1726)
Grass and pollen (4)
Guidances (29)
Healthcare (7128)
Huntington's disease (11)
IgA nephropathy (10)
Immunology and inflammation (38)
Indications (18)
Infectious disease (1151)
Inflammatory bowel disease (51)
Inflation Reduction Act (1)
Influenza (29)
Intellectual property (45)
Interviews (44)
IPO (7373)
IRA (5)
Job creations (1298)
Job search strategy (291)
Kidney cancer (6)
Labor market (4)
Layoffs (118)
Leadership (4)
Legal (2510)
Liver cancer (46)
Lung cancer (245)
Lymphoma (89)
Machine learning (3)
Management (10)
Manufacturing (150)
MASH (32)
Medical device (4152)
Medtech (4152)
Mergers & acquisitions (7271)
Metabolic disorders (269)
Multiple sclerosis (38)
NASH (8)
Neurodegenerative disease (38)
Neuropsychiatric disorders (5)
Neuroscience (821)
NextGen: Class of 2025 (2281)
Non-profit (2051)
Now hiring (14)
Obesity (105)
Opinion (46)
Ovarian cancer (32)
Pain (39)
Pancreatic cancer (48)
Parkinson's disease (76)
Partnered (6)
Patents (91)
Patient recruitment (54)
Peanut (16)
People (21713)
Pharmaceutical (14)
Phase I (8387)
Phase II (12504)
Phase III (10526)
Pipeline (635)
Policy (17)
Postmarket research (1233)
Preclinical (3730)
Press Release (26)
Prostate cancer (61)
Psychedelics (8)
Radiopharmaceuticals (98)
Rare diseases (170)
Real estate (2937)
Recruiting (8)
Regulatory (9278)
Reports (14)
Research institute (1113)
Resumes & cover letters (48)
Rett syndrome (4)
RSV (18)
Schizophrenia (28)
Series A (61)
Series B (42)
Service/supplier (6)
Sickle cell disease (22)
Spinal muscular atrophy (48)
Sponsored (13)
Startups (1342)
State (1)
Stomach cancer (9)
Supply chain (36)
Tariffs (4)
The Weekly (5)
Vaccines (234)
Venture capitalists (9)
Weight loss (44)
Women's health (11)
Worklife (2)
Date
Today (68)
Last 7 days (500)
Last 30 days (1514)
Last 365 days (16896)
2025 (6079)
2024 (16173)
2023 (16540)
2022 (22152)
2021 (23690)
2020 (21992)
2019 (17671)
2018 (13432)
2017 (13100)
2016 (12164)
2015 (13956)
2014 (10589)
2013 (8622)
2012 (9260)
2011 (9817)
2010 (8911)
Location
Africa (229)
Alabama (15)
Alaska (2)
Arizona (73)
Arkansas (6)
Asia (14775)
Australia (2427)
California (3330)
Canada (975)
China (282)
Colorado (130)
Connecticut (181)
Delaware (105)
Europe (36734)
Florida (462)
Georgia (92)
Idaho (15)
Illinois (249)
India (12)
Indiana (138)
Iowa (6)
Japan (94)
Kansas (44)
Kentucky (18)
Louisiana (3)
Maine (26)
Maryland (432)
Massachusetts (2460)
Michigan (116)
Minnesota (141)
Missouri (55)
Montana (9)
Nebraska (9)
Nevada (28)
New Hampshire (18)
New Jersey (970)
New Mexico (10)
New York (947)
North Carolina (992)
North Dakota (4)
Northern California (1472)
Ohio (129)
Oklahoma (8)
Oregon (12)
Pennsylvania (587)
Puerto Rico (3)
Rhode Island (19)
South America (392)
South Carolina (18)
Southern California (1200)
Tennessee (50)
Texas (512)
United States (12560)
Utah (98)
Virginia (70)
Washington D.C. (42)
Washington State (293)
West Virginia (2)
Wisconsin (49)
263,081 Results for "romark laboratories l c".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
L&C Bio Secures World’s First NMPA Approval for ‘MegaDerm Plus’ in China
January 22, 2025
·
3 min read
BioMidwest
C2N’s Precivity™ Tests are Now Offered Through Mayo Clinic Laboratories
C2N Diagnostics, LLC, which provides exceptional clinical laboratory services and advanced diagnostic solutions in the field of brain health, has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for inclusion of C2N’s Precivity tests in Mayo Clinic Laboratories’ test offerings to its clients.
June 27, 2024
·
4 min read
Deals
Frontage Laboratories Acquires Accelera S.r.l.'s Bioanalytical and DMPK Businesses
Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
January 2, 2024
·
5 min read
Press Releases
Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL.
May 1, 2025
·
6 min read
Press Releases
PD-L1 Measured by Blood Test Reveals Important Clinical Information
March 12, 2025
·
2 min read
Business
Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
Daxor Corporation today announces the appointment of Dr. John L. Jefferies, M.D., M.B.A., M.P.H., F.A.C.C., F.A.H.A., F.A.A.P., F.H.F.S.A., F.E.S.C., F.R.C.P.E., as Chief Medical Officer.
June 5, 2024
·
4 min read
Press Releases
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
March 27, 2025
·
7 min read
Press Releases
EveryONE Medicines Announces Appointment of Michelle L. Mellion, MD, as Chief Medical Officer
April 16, 2025
·
4 min read
Press Releases
Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
February 19, 2025
·
9 min read
Press Releases
Samsung Invests in C2N Diagnostics
March 13, 2025
·
4 min read
1 of 26,309
Next
